NCT03951220 2025-08-19
LOOMIS
Oxford University Hospitals NHS Trust
Completed
Clinical Trials
6 trialsNCT06504524 2025-06-27
A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US
Pfizer
Completed
NCT05061095 2024-12-27
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
UNC Lineberger Comprehensive Cancer Center
Completed
NCT05932290 2024-10-29
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
Pfizer
Completed
NCT05565391 2024-05-21
A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma
Pfizer
Completed
NCT00897910 2016-01-11
Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma
Barbara Ann Karmanos Cancer Institute
Terminated